Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
pipeline
Biotech
JPM: Novo CSO craves 'different flavors' of pipeline innovation
Novo is seeking to strengthen its obesity offerings while pursuing other indications that intersect with metabolism.
Darren Incorvaia
Jan 13, 2026 7:45am
Lyra ditches sole rhinosinusitis asset, lays off all employees
Jan 13, 2026 4:30am
J&J junks $1.2B eczema therapy while Genmab drops cancer drug
Jan 2, 2026 9:05am
2 biotechs scrounge for funds in year-end dealmaking spree
Dec 23, 2025 1:45pm
Verge drops sole clinical candidate in return to AI roots
Dec 18, 2025 10:04pm
Voyager jettisons staff, Novartis hands back 2 programs
Dec 17, 2025 4:50pm